Guangzhou LBP Medicine Science & Technology Co., Ltd.
SSE:688393.SS
28.33 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 21.291 | 21.019 | 29.33 | 75.282 | 83.622 | 72.804 | 62.42 | 49.741 | 46.86 | 38.404 | 27.734 | 27.15 |
| Depreciation & Amortization
| 40.75 | 40.993 | 35.686 | 18.579 | 10.463 | 11.33 | 12.397 | 13.101 | 12.043 | 4.953 | 2.959 | 3.28 |
| Deferred Income Tax
| 0 | -10.656 | -3.607 | 5.778 | 1.301 | 0.719 | -1.099 | -0.272 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 7.609 | 7.355 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -49.519 | -56.604 | -69.9 | -28.849 | -5.963 | 2.891 | -11.353 | 20.158 | -18.379 | -46.336 | -27.547 | -47.693 |
| Accounts Receivables
| -7.451 | -9.292 | -36.173 | -35.004 | -20.14 | -4.474 | -20.869 | -9.07 | 0 | -44.747 | -8.718 | 0 |
| Inventory
| -30.234 | -30.49 | -23.075 | -16.647 | -13.802 | 3.189 | -1.401 | -1.078 | 3.714 | -12.864 | -7.132 | 0.084 |
| Accounts Payables
| 0 | -6.167 | -7.045 | 17.023 | 26.679 | 3.458 | 12.015 | 30.579 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -11.835 | -10.656 | -3.607 | 5.778 | 1.301 | 0.719 | -9.952 | 21.237 | -22.093 | -33.472 | -20.415 | -47.777 |
| Other Non Cash Items
| -8.979 | 22.37 | 10.598 | -18.531 | 3.304 | 2.713 | 1.888 | 0.918 | 2.851 | 2.283 | 1.689 | 2.019 |
| Operating Cash Flow
| 3.543 | 17.121 | 9.716 | 59.614 | 91.426 | 89.739 | 65.351 | 83.919 | 43.374 | -0.697 | 4.836 | -15.245 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -23.646 | -37.745 | -72.168 | -143.341 | -62.448 | -35.544 | -43.92 | -33.43 | -15.789 | -54.703 | -15.246 | -5.954 |
| Acquisitions Net
| 0 | -1.252 | 3.572 | -31.853 | 62.642 | 36.116 | -2.501 | 33.797 | 15.928 | -6.63 | 0 | -1.079 |
| Purchases Of Investments
| -73.253 | -220.03 | -657.811 | -1,113.64 | -519.18 | -192 | -232.5 | -201.147 | -89.5 | -78 | -144.683 | 0 |
| Sales Maturities Of Investments
| 153.984 | 220.929 | 612.853 | 839.292 | 398.125 | 167.19 | 230.517 | 152.456 | 82.829 | 107.693 | 117.796 | 0 |
| Other Investing Activites
| 0.035 | 5.4 | -1.368 | 2.928 | -62.448 | -35.544 | 1.421 | -33.43 | -15.789 | 0 | 0 | 0 |
| Investing Cash Flow
| 57.12 | -32.698 | -114.921 | -446.615 | -183.309 | -59.781 | -46.983 | -81.755 | -22.321 | -31.639 | -42.134 | -7.034 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -13.9 | 6.898 | 6.513 | 7 | 0 | 0 | -0.6 | 0 | -6 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -14.507 | -13.468 | -25.202 | -26.135 | 0 | -17.5 | -16.524 | -21 | -9.8 | -0.175 | -0.049 | 0 |
| Other Financing Activities
| -6.313 | -0.324 | -4.081 | -10.39 | 638.434 | 0.008 | -0.01 | -3.4 | 0 | 10.279 | 68.201 | 29.544 |
| Financing Cash Flow
| -34.721 | -6.894 | -21.401 | -29.525 | 639.334 | -19.219 | -17.134 | -24.4 | -15.8 | 10.104 | 68.201 | 29.544 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.124 | 0.08 | 0.142 | -0.055 | -0.102 | 0 | -0.009 | -0 | 0 | -0 | 0 | -0 |
| Net Change In Cash
| 25.818 | -22.391 | -126.463 | -416.581 | 547.349 | 10.739 | 1.226 | -22.237 | 5.253 | -22.231 | 30.904 | 7.265 |
| Cash At End Of Period
| 93.43 | 67.612 | 90.003 | 216.466 | 633.047 | 85.698 | 74.959 | 73.733 | 95.97 | 30.925 | 53.156 | 22.253 |